About Intend Research, LLC
"Clinical Trials and Medical Research"
Clinical Trials at Intend Research, LLC
During the past decade, Intend Research, LLC conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 12 clinical trials were completed, i.e. on
average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 12 clinical trials were completed. i.e. 63.2%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Intend Research, LLC" #1 sponsor was "Eli Lilly and Company" with 17 trials, followed by "Janssen Research & Development, LLC" with 2 trials
sponsored, "Achieve Life Sciences" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Gan and Lee Pharmaceuticals, USA"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Intend Research, LLC"
#1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Intend Research, LLC
According to Clinical.Site data, the most researched conditions in "Intend Research, LLC" are
"Type 2 Diabetes" (6 trials), "Obesity" (5 trials), "Overweight" (4 trials), "Type 2 Diabetes Mellitus" (4 trials) and "Depressive Disorder, Major" (2 trials). Many other conditions were trialed in "Intend Research, LLC" in a lesser frequency.
Clinical Trials Intervention Types at Intend Research, LLC
Most popular intervention types in "Intend Research, LLC" are "Drug" (25 trials), "Behavioral" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Tirzepatide" (8 trials), "Dulaglutide" (3 trials), "Insulin Degludec" (3 trials) and "LY3209590" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Intend Research, LLC
The vast majority of trials in "Intend Research, LLC" are
26 trials for "All" genders.
Clinical Trials Status at Intend Research, LLC
Currently, there are NaN active trials in "Intend Research, LLC".
undefined are not yet recruiting,
undefined are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in Intend Research, LLC,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Intend Research, LLC, 1 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".